We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
+3.02%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$751M
AUM Growth
-$32.5M
Cap. Flow
+$2.11M
Cap. Flow %
0.28%
Top 10 Hldgs %
35.59%
Holding
104
New
11
Increased
46
Reduced
31
Closed
15

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$22.1M
2
SYK icon
Stryker
SYK
+$18.4M
3
VRDN icon
Viridian Therapeutics
VRDN
+$14.4M
4
MCK icon
McKesson
MCK
+$12.9M
5
UNH icon
UnitedHealth
UNH
+$11.4M

Top Sells

Rank Stock Value
1
TFX icon
Teleflex
TFX
+$23.8M
2
LBPH
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
+$16.4M
3
AGIO icon
Agios Pharmaceuticals
AGIO
+$12.7M
4
LLY icon
Eli Lilly
LLY
+$10.1M
5
UTHR icon
United Therapeutics
UTHR
+$9.76M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XFOR icon
101
X4 Pharmaceuticals
XFOR
$425M
– –
-27,291
Closed -$548K
LENZ
102
LENZ Therapeutics
LENZ
$158M
– –
-139,357
Closed -$3.31M
CDMO
103
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
– –
-719,965
Closed -$8.19M
LBPH
104
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
– –
-491,272
Closed -$16.4M
1 2 3 4
5

Similar funds

LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $967M AUM
GHC
Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Parkman Healthcare Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Parkman Healthcare Partners held 104 positions worth $751M, down 4.2% from $783M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Parkman Healthcare Partners's Q4 2024 filing shows 11 new, 46 increased, 31 reduced and 15 closed positions. Its largest new stake was McKesson: 23,000 shares worth $13.1M. The largest sale was Teleflex, an estimated $23.8M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Parkman Healthcare Partners's largest Q4 2024 buy was McKesson: 23,000 shares worth $13.1M.
  • Parkman Healthcare Partners added most to Gilead Sciences in Q4 2024, an estimated $22.1M increase.
  • Parkman Healthcare Partners's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $10.1M.
  • Parkman Healthcare Partners fully exited Teleflex in Q4 2024, selling an estimated $23.8M.
  • Parkman Healthcare Partners's ten largest holdings make up 36% of its $751M portfolio in Q4 2024.
  • Parkman Healthcare Partners opened 11 new positions and closed 15 in Q4 2024.
  • Parkman Healthcare Partners's portfolio value fell 4.2% quarter-over-quarter to $751M.

Based on Parkman Healthcare Partners's 13F filing for Q4 2024, filed 14 Feb 2025.